Source: Abstract# FRI-183 Population level outcomes and cost-effectiveness of expanding guidance for age-based hepatitis C testing in the United States—J.A. Barocas, et al.
Study Aims and Results: The current U.S. guidelines recommend one-time hepatitis C virus (HCV) testing for all people born 1945–1965, targeted testing of high-risk persons. This study simulated 4 HCV testing and treatment strategies in the U.S.:
- Current standard of care
- Routine testing for all persons aged ≥40
- Testing people aged ≥30 years
- Testing people aged ≥18 years
The expanded age-based testing strategies identified approximately 5% more people with an increased cure rate of 6%.
Conclusions: This study found that testing all adults for HCV is an economically sound strategy.
Editorial Comments: It feels uncomfortable when the value of healthcare is reduced to cost-effectiveness, however, sometimes that is an argument that catches the most attention. This year’s EASL presentations have at least 4 abstracts that show the gains that can be made when HCV testing and treating includes more people in the U.S. For more information about this, see:
- Abstract #FRI-179 Integrated healthcare system implementation of one time hepatitis C virus testing for patients born between 1945 and 1965 with linkage to care (J.M. Levin, et al.)
- Abstract #FRI-458 The Cost-effectiveness of a one time hepatitis C virus antibody test followed by treatment for all Americans ages 18 and older as compared to current testing recommendations in the United States (D.B. Rein, et al.)
- Abstract #FRI-478 An alternative screening strategy for hepatitis C virus infection among Americans not belonging in the baby boomer birth cohort (P. Udompap, et al.)